Cancer HealthCast: New Technologies Lead to Major Breakthroughs in Cancer Detection, Screening at NCI
Two key programs are playing a vital role in detecting and diagnosing cancer as well as reducing the overall burden on patients and their families.
The National Cancer Institute is utilizing a host of new technologies to diagnose and detect cancer thanks to its Innovative Molecular Analysis Technologies (IMAT) and Informatics Technology for Cancer Research (ITCR) programs. These programs are developing methods that are enhancing cancer research, including artificial intelligence.
Dr. Kelly Crotty, program director for NCI’s Center for Strategic Scientific Initiatives, said not only have the programs helped researchers better identify and screen for cancer, but also they’ve been instrumental in driving progress in clinical care. Crotty also shares updates about NCI’s Liquid Biopsy Consortium and discusses the benefits and challenges she’s seeing with AI.
-
Dr. Kelly Crotty Program Director, Center for Strategic Scientific Initiatives NCI
-
Agencies Want to 'Demystify' Generative AI to See Greater Adoption
Managing concerns over generative AI capabilities requires sharing best practices and use cases for workflows.
2m read -
Cancer HealthCast: This Unique Network Closes Research Gaps in Cancer Genomics
Dr. Leah Mechanic, Program Director at NCI and Dr. Bettina Drake, Professor at Washington University School of Medicine
24m listen -
USDA to Release AI Strategy in Upcoming Months
Deputy CDO Freddy Diaz said a plan for AI following its new data strategy is in the works and will focus more on workforce.
2m read -
DHS AI Roadmap Outlines Trustworthy Development Plan
DHS Secretary Alejandro Mayorkas sees the technology supporting criminal investigations, risk mitigation after disasters and training.
3m read